Search

72 results for “prevention”

• Case ReportOpen Access

  Clofazimine‑induced premaculopathy in a vitiliginous patient

  Nirupama Kasturi, Renuka Srinivasan

  Vol. 7 · Issue 3 · pp. 149–151

  https://doi.org/10.4103/0976-500X.189685
  Full text ↗PDF

• Research PaperOpen Access

  Asenapine modulates nitric oxide release and calcium movements in cardiomyoblasts

  Elena Grossini, Carla Gramaglia, Serena Farruggio, Lara Camillo, David Mary, Giovanni Vacca, Patrizia Zeppegno

  Vol. 7 · Issue 1 · pp. 6–14

  https://doi.org/10.4103/0976-500X.179358
  Full text ↗PDF

• Research PaperOpen Access

  Factors influencing adherence to anti‑craving medications and drinking outcomes in patients with alcohol dependence: A hospital‑based study

  K. Lohit, Chanda Kulkarni, R. B. Galgali

  Vol. 7 · Issue 2 · pp. 72–79

  https://doi.org/10.4103/0976-500X.184770
  Full text ↗PDF

• Molecules of the MillenniumOpen Access

  Macitentan: An important addition to the treatment of pulmonary arterial hypertension

  Anjan Khadka, Dick B Singh Brashier, Anantharamu Tejus, Ashok Kumar Sharma

  Vol. 6 · Issue 1 · pp. 53–57

  https://doi.org/10.4103/0976-500X.149151
  Full text ↗PDF

• Case ReportOpen Access

  Exercise‑induced anaphylaxis and antileukotriene montelukast

  Sapna Gajbhiye, Rajendra Prasad Agrawal, Shubham Atal, Vikalp Tiwari, Pradeep Phadnis

  Vol. 6 · Issue 3 · pp. 163–165

  https://doi.org/10.4103/0976-500X.162007
  Full text ↗PDF

• Research PaperOpen Access

  Identification of core active disaccharides in heparin for HGF‑inducing activity

  Takashi Kato, Ryoichi Sakiyama, Kiyomasa Oka, Toshikazu Nakamura

  Vol. 6 · Issue 2 · pp. 77–82

  https://doi.org/10.4103/0976-500X.155483
  Full text ↗PDF

• EditorialOpen Access

  Are we moving towards a new definition of essential medicines?

  Manikandan S

  Vol. 6 · Issue 3 · pp. 123–5

  https://doi.org/10.4103/0976-500X.162008
  Full text ↗PDF

• Research LetterOpen Access

  Structural aberration in R282K genetic mutation and antiviral drug-resistant H7N9 bird flu

  Somsri Wiwanitkit, Viroj Wiwanitkit

  Vol. 6 · Issue 1 · pp. 34–34

  https://doi.org/10.4103/0976-500X.149142
  Full text ↗PDF

• Open Access

  Naloxegol: First oral peripherally acting mu opioid receptor antagonists for opioid-induced constipation

  Tejus Anantharamu, Sushil Sharma, Ajay Kumar Gupta, Navdeep Dahiya, Dick B. Singh Brashier

  Vol. 6 · Issue 3 · pp. 188–192

  https://doi.org/10.4103/0976-500X.162015
  Full text ↗PDF

• CommentaryOpen Access

  The new factor Xa inhibitor: Apixaban

  Sangeeta Bhanwra, Kaza Ahluwalia

  Vol. 5 · Issue 1 · pp. 12–14

  https://doi.org/10.4103/0976-500X.124409
  Full text ↗PDF

• CorrespondenceOpen Access

  European Heart and Rhythm Association guidelines on new oral anticoagulants: A bold step forward

  Vishal Sehgal, Sukhminder Jit Singh Bajwa

  Vol. 5 · Issue 2 · pp. 167–169

  https://doi.org/10.4103/0976-500X.130147
  Full text ↗PDF

• Research LetterOpen Access

  Pharmacovigilance and adverse drug reaction reporting perspectives among interns and postgraduates of a teaching hospital

  Raghava Sharma, Adithi Kellarai

  Vol. 5 · Issue 4 · pp. 248–250

  https://doi.org/10.4103/0976-500X.142436
  Full text ↗PDF

• Mini ReviewOpen Access

  Statin induced diabetes and its clinical implications

  Umme Aiman, Ahmad Najmi, Rahat Ali Khan

  Vol. 5 · Issue 3 · pp. 181–185

  https://doi.org/10.4103/0976-500X.136097
  Full text ↗PDF

• EditorialOpen Access

  Pharmacovigilance in Calabria (Italy): Local experiences resonate international relevance

  Emilio Russo, Giovambattista De Sarro

  Vol. 4 · Issue Supplement 1 · pp. 1–3

  https://doi.org/10.4103/0976-500X.120938
  Full text ↗PDF

• Mini ReviewOpen Access

  Adverse drug reactions in the elderly

  Dhriti K. Brahma, Julie B. Wahlang, Maxilline D. Marak, Marlina Ch. Sangma

  Vol. 4 · Issue 2 · pp. 91–92

  https://doi.org/10.4103/0976-500X.110872
  Full text ↗PDF

• Case ReportOpen Access

  Diclofenac induced acute renal failure in a decompensated elderly patient

  Pallavi Dhanvijay, Arup K. Misra, Sushil K. Varma

  Vol. 4 · Issue 2 · pp. 155–157

  https://doi.org/10.4103/0976-500X.110916
  Full text ↗PDF

• WebwiseOpen Access

  The portal for rare diseases and orphan drugs

  Jatinder Singh

  Vol. 4 · Issue 2 · pp. 168–9

  Full text ↗PDF

• Case ReviewOpen Access

  Management of dermatologic toxicities associated with monoclonal antibody epidermal growth factor receptor inhibitors: A case review

  Christian Leporini, Francesca Saullo, Gianfranco Filippelli, Antonio Sorrentino, Maria Lucia, Gino Perri, Gaetana Gattuta, Stefania Infusino, Rosa Toscano, Gianluca Dima, Virginia Olivito, Laura Paletta, Ugo Bottoni, Giovambattista Sarro

  Vol. 4 · Issue Supplement 1 · pp. S78–S79

  https://doi.org/10.4103/0976-500X.120966
  Full text ↗PDF

• Research LetterOpen Access

  Cross sectional surveillance of drug dispensing efficacy, availability and quality of labelling by patient care indicators in health care facilities

  Lukshmy M. Hettihewa, Kalana Jayarathna, Sewwandi Subasinghe

  Vol. 4 · Issue 2 · pp. 142–143

  https://doi.org/10.4103/0976-500X.110898
  Full text ↗PDF

• Mini ReviewOpen Access

  Iptakalim: A novel multi-utility potassium channel opener

  (Kir6.1s) (Kir6.1s), regulatory sulphonylurea subunits (SUR).[3] IPT shows high selectivity for cardiac KATP (SUR2A/Kir6.2), vascular KATP (SUR2B/Kir6.1 or SUR6B/Kir6.2). Because

  Vol. 3 · Issue 1 · pp. 12–14

  https://doi.org/10.4103/0976-500X.92495
  Full text ↗PDF